Applications Published 3 April 2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Henceforth Hibernia 1191923*
Pharmaceutical dosage form for pulsatile delivery of (D-threo)-methylphenidate and a second CNS stimulant
Pharmaquest 1191924*
Sustained release dosage form unit having latex coating and method of making the same
Abbott Laboratories 1191925*
New formulation
AstraZeneca 1191926*
Microreservoir system on the basis of polysiloxanes and ambiphilic solvents
LTS Lohmann Therapie-Systeme 1191927*
Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
Ragavan, Vanaja; Laties, Alan 1191928*
Methods for the treatment of asthma using S-oxybutynin
Sepracor 1191930*
1-(4-sulphamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
Temple University of the Commonwealth System of Higher Education 1191931*
Production of agglomerates of inogatran and the compound inogratran anhydrate
AstraZeneca 1191932*
Nasal delivery of apomorphine
Nastech Pharmaceutical 1191933*
IL-8 receptor antagonists
SmithKline Beecham 1189934*
A method for the treatment or prevention of coronary graft vasospasm
Orion Corp 1191935*
Production of polygalacturonides and their use as food additives
Lang, Christine 1191936*
Adhesive N,O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
Chitgenics 1191937*
Immunity generation
Bondco 897 1191938*
Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
Zengen 1191939*
Tumour necrosis factor receptor 5
Human Genome Sciences 1191940*
A method for the prophylaxis and/or treatment of medical disorders
Murdoch Children's Research Institute 1191941*
Treatment of endometriosis with antileukoprotease
Reprogen 1191942*
Novel anti-allergic agents
Allergene 1191943*
Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
Genentech 1191944*
Methods and compsns for control of bone formation via modulation of leptin activity
Baylor College of Medicine 1191945*
Methods for treating AVM using radioactive compsns
Micro Therapeutics 1191947*
Benzene derivatives, preparation method and pharmaceutical compsns containing same
Sanofi-Synthelabo 1192122*
Novel monomers with quaternary amino groups, method for making same, and novel (co)polymers obtained from said novel monomers
Atofina 1192123*
Substituted benzamide inhibitors of rhinovirus 3C protease
Agouron Pharmaceuticals 1192127*
Thiol derivative, metallo-beta-lactamase inhibitors
Merck 1192128*
Pharmaceutical compounds
Nicox 11992129*
Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
Warner-Lambert 1192131*
Serine protease inhibitors
Eli Lilly 1192132*
N-cyclopentyl modulators of chemokine receptor activity
Merck 1192133*
Serine protease inhibitors
Eli Lilly 1192135*
Compounds for the modulation of PPAR(g) activity
Tularik; Japan Tobacco 1192137*
Preparation of quinoline-substituted carbonate and carbamate derivatives
Abbott Laboratories 1192139*
Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
Warner-Lambert 1192143*